| Regulatory Consultancy |
|
Regulatory consultancy becomes a critical part of the global medical business activities. Marketing medical products across the border is not easy due to the difference in those policies regulating medical products in each country. Getting the regulatory approval for medical products in China requires both the knowledge in the SFDA’s regulations and the experience in working with the regulatory bodies.
Each year, our consultants have secured the approval of dozens of the medical products in China including pharmaceutical, traditional Chinese medicine, medical device, nutraceutical, and cosmetic products. Our team's group experience has been of tremendous help to our clients.
The scope of our regulatory consultancies includes:
Testimonial“The extensive knowledge the team of China Healthcare Group have in the SFDA regulations played an instrumental role in helping us get the speedy approval of our medical device product in China. We were thrilled about this”-Sabine Werner, Managing Director of DiActiv GmbH, Germany. |
| < Prev |
|---|
Service Activities
Industrial News
- China Aoxing Pharmaceutical Company Receives Government Approval for Increased Ownership of its Main
- Reform to target hefty medicine costs
- China to develop traditional medicine vigorously
- Novartis to move Indian R&D operations to China: Financial Times
- India and China competing on pharma potential